Cell membrane disintegration and extracellular vesicle release in a model of different size and charge PAMAM dendrimers effects on cultured endothelial cells

References

• Abbasi, E., S. F. Aval, A. Akbarzadeh, M. Milani, H. T. Nasrabadi, S. W. Joo, Y. Hanifehpour, K. Nejati-Koshki, and R. Pashaei-Asl. 2014. “Dendrimers: Synthesis, Applications, and Properties.” Nanoscale Research Letters 9 (1): 247. doi:10.1186/1556-276X-9-247.
   PubMed Web of Science ®Google Scholar
• Albertazzi, L., L. Gherardini, M. Brondi, S. Sulis Sato, A. Bifone, T. Pizzorusso, G. M. Ratto, and G. Bardi. 2013. “In Vivo Distribution and Toxicity of PAMAM Dendrimers in the Central Nervous System Depend on Their Surface Chemistry.” Molecular Pharmaceutics 10 (1): 249–260. doi:10.1021/mp300391v.
   PubMed Web of Science ®Google Scholar
• Berényi, S., J. Mihály, A. Wacha, O. Tőke, and A. Bóta. 2014. “A Mechanistic View of Lipid Membrane Disrupting Effect of PAMAM Dendrimers.” Colloids and Surfaces. B, Biointerfaces 118: 164–171. doi:10.1016/j.colsurfb.2014.03.048
   PubMed Web of Science ®Google Scholar
• Bertero, A., A. Boni, M. Gemmi, M. Gagliardi, A. Bifone, and G. Bardi. 2014. “Surface Functionalisation Regulates Polyamidoamine Dendrimer Toxicity on Blood–brain Barrier Cells and the Modulation of Key Inflammatory Receptors on Microglia.” Nanotoxicology 8 (2): 158–168. doi:10.3109/17435390.2013.765054.
   PubMed Web of Science ®Google Scholar
• Biricova, V., and A. Laznickova. 2009. “Dendrimers: Analytical Characterization and Applications.” Bioorganic Chemistry 37 (6): 185–192. doi:10.1016/j.bioorg.2009.07.006.
   PubMed Web of Science ®Google Scholar
• Cao, Y., Y. Gong, L. Liu, Y. Zhou, X. Fang, C. Zhang, Y. Li, and J. Li. 2017. “The Use of Human Umbilical Vein Endothelial Cells (HUVECs) as an In Vitro Model to Assess the Toxicity of Nanoparticles to Endothelium: A Review.” Journal of Applied Toxicology 37 (12): 1359–1369. doi:10.1002/jat.3470.
   PubMed Web of Science ®Google Scholar
• Celermajer, D. S., C. K. Chow, E. Marijon, N. M. Anstey, and K. S. Woo. 2012. “Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection.” Journal of the American College of Cardiology 60 (14): 1207–1216. doi:10.1016/j.jacc.2012.03.074.
   PubMed Web of Science ®Google Scholar
• Choi, A. M. K., S. W. Ryter, and B. Levine. 2013. “Autophagy in Human Health and Disease.” New England Journal of Medicine 368 (7): 651–662. doi:10.1056/NEJMra1205406.
   PubMed Web of Science ®Google Scholar
• De Paoli, S. H., T. Z. Tegegn, O. K. Elhelu, M. B. Strader, M. Patel, L. L. Diduch, I. D. Tarandovskiy., et al. 2018. “Dissecting the Biochemical Architecture and Morphological Release Pathways of the Human Platelet Extracellular Vesiculome.” Cellular and Molecular Life Sciences 75 (20): 3781–3801. doi:10.1007/s00018-018-2771-6.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia, M. A., A. K. Patri, J. Simak, J. B. Hall, J. Semberova, S. H. De Paoli Lacerda, and S. E. Mcneil. 2012. “Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets In Vitro.” Molecular Pharmaceutics 9 (3): 382–393. doi:10.1021/mp200463e.
   PubMed Web of Science ®Google Scholar
• Feliu, N., P. Kohonen, J. Ji, Y. Zhang, H. L. Karlsson, L. Palmberg, A. Nyström, and B. Fadeel. 2015. “Next-Generation Sequencing Reveals Low-Dose Effects of Cationic Dendrimers in Primary Human Bronchial Epithelial Cells.” ACS Nano 9 (1): 146–163. doi:10.1021/nn5061783.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., P. Chakraborty, A. Chakrabarti, M. Ghosh, A. Mandal, P. Saha, A. Mukherjee, S. Acharya, and M. Ray. 2016. “Biological Activity of Dendrimer-methylglyoxal Complexes for Improved Therapeutic Efficacy against Malignant Cells.” RSC Advances 6 (8): 6631–6642. doi:10.1039/C5RA23477H.
   Web of Science ®Google Scholar
• Gonzalo, S., I. Rodea-Palomares, F. Leganés, E. García-Calvo, R. Rosal, and F. Fernández-Piñas. 2015. “First Evidences of PAMAM Dendrimer Internalization in Microorganisms of Environmental Relevance: A Linkage with Toxicity and Oxidative Stress.” Nanotoxicology 9 (6): 706–718. doi:10.3109/17435390.2014.969345.
   PubMed Web of Science ®Google Scholar
• Hall, J. B., M. A. Dobrovolskaia, A. K. Patri, and S. E. Mcneil. 2007. “Characterization of Nanoparticles for Therapeutics.” Nanomedicine (London, England) 2 (6): 789–803. doi:10.2217/17435889.2.6.789
   PubMed Web of Science ®Google Scholar
• He, X., Z. Qu, F. Xu, M. Lin, J. Wang, X. Shi, and T. Lu. 2014. “Molecular Analysis of Interactions between Dendrimers and Asymmetric Membranes at Different Transport Stages.” Soft Matter 10 (1): 139–148. doi:10.1039/C3SM51990B.
   PubMed Web of Science ®Google Scholar
• Hong, S., A. U. Bielinska, A. Mecke, B. Keszler, J. L. Beals, X. Shi, L. Balogh, B. G. Orr, J. R. Baker, and M. M. Banaszak Holl. 2004. “Interaction of Poly(amidoamine) Dendrimers with Supported Lipid Bilayers and Cells: Hole Formation and the Relation to Transport.” Bioconjugate Chemistry 15 (4): 774–782. doi:10.1021/bc049962b.
   PubMed Web of Science ®Google Scholar
• Hong, S., P. R. Leroueil, E. K. Janus, J. L. Peters, M.-M. Kober, M. T. Islam, B. G. Orr, J. R. Baker, and M. M. Banaszak Holl. 2006. “Interaction of Polycationic Polymers with Supported Lipid Bilayers and Cells: Nanoscale Hole Formation and Enhanced Membrane Permeability.” Bioconjugate Chemistry 17 (3): 728–734. doi:10.1021/bc060077y.
   PubMed Web of Science ®Google Scholar
• Jevprasesphant, R., J. Penny, R. Jalal, D. Attwood, N. B. Mckeown, and A. D’emanuele. 2003. “The Influence of Surface Modification on the Cytotoxicity of PAMAM Dendrimers.” International Journal of Pharmaceutics 252 (1–2): 263–266. doi:10.1016/S0378-5173(02)00623-3
   PubMed Web of Science ®Google Scholar
• Jones, C. F., R. A. Campbell, Z. Franks, C. C. Gibson, G. Thiagarajan, A. Vieira-De-Abreu, S. Sukavaneshvar., et al. 2012. “Cationic PAMAM Dendrimers Disrupt Key Platelet Functions.” Molecular Pharmaceutics 9 (6): 1599–1611. doi:10.1021/mp2006054.
   PubMed Web of Science ®Google Scholar
• Kannan, R. M., E. Nance, S. Kannan, and D. A. Tomalia. 2014. “Emerging Concepts in Dendrimer-based Nanomedicine: from Design Principles to Clinical Applications.” Journal of Internal Medicine 276 (6): 579–617. doi:10.1111/joim.12280.
   PubMed Web of Science ®Google Scholar
• Kelly, C. V., P. R. Leroueil, B. G. Orr, M. M. B. Holl, and I. Andricioaei. 2008. “Poly(amidoamine) Dendrimers on Lipid Bilayers II: Effects of Bilayer Phase and Dendrimer Termination.” The Journal of Physical Chemistry B 112 (31): 9346–9353. doi:10.1021/jp8013783.
   PubMed Web of Science ®Google Scholar
• Keszthelyi, T., G. Hollo, G. Nyitrai, J. Kardos, and L. Heja. 2015. “Bilayer Charge Reversal and Modification of Lipid Organization by Dendrimers as Observed by Sum-Frequency Vibrational Spectroscopy.” Langmuir 31 (28): 7815–7825. doi:10.1021/acs.langmuir.5b00734.
   PubMed Web of Science ®Google Scholar
• Kim, J. A., C. Åberg, G. De Cárcer, M. Malumbres, A. Salvati, and K. A. Dawson. 2013. “Low Dose of Amino-Modified Nanoparticles Induces Cell Cycle Arrest.” ACS Nano 7 (9): 7483–7494. doi:10.1021/nn403126e.
   PubMed Web of Science ®Google Scholar
• Labieniec-Watala, M., M. Szwed, J. Hertel, and E. Wisnik. 2017. “Low Concentrations of Cationic PAMAM Dendrimers Affect Lymphocyte Respiration in In Vitro Studies.” Current Pharmaceutical Biotechnology 18 (2): 150–157. doi:10.2174/1389201017666161229153018.
   PubMed Web of Science ®Google Scholar
• Lee, J. H., K. E. Cha, M. S. Kim, H. W. Hong, D. J. Chung, G. Ryu, and H. Myung. 2009. “Nanosized Polyamidoamine (PAMAM) Dendrimer-Induced Apoptosis Mediated by Mitochondrial Dysfunction.” Toxicology Letters 190 (2): 202–207. doi:10.1016/j.toxlet.2009.07.018.
   PubMed Web of Science ®Google Scholar
• Lee, H., and R. G. Larson. 2006. “Molecular Dynamics Simulations of PAMAM Dendrimer-Induced Pore Formation in DPPC Bilayers with a Coarse-Grained Model.” The Journal of Physical Chemistry B 110 (37): 18204–18211. doi:10.1021/jp0630830.
   PubMed Web of Science ®Google Scholar
• Lee, C. C., J. A. Mackay, J. M. Frechet, and F. C. Szoka. 2005. “Designing Dendrimers for Biological Applications.” Nature Biotechnology 23 (12): 1517–1526. doi:10.1038/nbt1171
   PubMed Web of Science ®Google Scholar
• Li, Z., J. C. Barnes, A. Bosoy, J. F. Stoddart, and J. I. Zink. 2012. “Mesoporous Silica Nanoparticles in Biomedical Applications.” Chemical Society Reviews 41 (7): 2590–2605. doi:10.1039/c1cs15246g.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Y. Pang, M. R. Toh, and G. N. Chiu. 2015. “Dual-functionalized Poly(amidoamine) Dendrimers with Poly(ethylene Glycol) Conjugation and Thiolation Improved Blood Compatibility.” Journal of Pharmacy and Pharmacology 67 (11): 1492–1502. doi:10.1111/jphp.12457.
   PubMed Web of Science ®Google Scholar
• Lombardo, D., P. Calandra, E. Bellocco, G. Lagana, D. Barreca, S. Magazu, U. Wanderlingh, and M. A. Kiselev. 2016. “Effect of Anionic and Cationic Polyamidoamine (PAMAM) Dendrimers on a Model Lipid Membrane.” Biochim Biophys Acta 1858 (11): 2769–2777. doi:10.1016/j.bbamem.2016.08.001.
   PubMed Web of Science ®Google Scholar
• Maiti, P. K., T. Çaǧın, G. Wang, and W. A. Goddard. 2004. “Structure of PAMAM Dendrimers:  Generations 1 Through 11.” Macromolecules 37 (16): 6236–6254. doi:10.1021/ma035629b.
   Web of Science ®Google Scholar
• Malik, N., R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J. W. Weener, E. W. Meijer, W. Paulus, and R. Duncan. 2000. “Dendrimers:: Relationship between Structure and Biocompatibility In Vitro, and Preliminary Studies on the Biodistribution of 125I-Labelled Polyamidoamine Dendrimers In Vivo.” Journal of Controlled Release 65: 133–148. doi:10.1016/S0168-3659(99)00246-1.
   PubMed Web of Science ®Google Scholar
• Martin, H., H. Kinns, N. Mitchell, Y. Astier, R. Madathil, and S. Howorka. 2007. “Nanoscale Protein Pores Modified with PAMAM Dendrimers.” Journal of the American Chemical Society 129 (31): 9640–9649. doi:10.1021/ja0689029.
   PubMed Web of Science ®Google Scholar
• Matz, R. L., B. Erickson, S. Vaidyanathan, J. F. Kukowska-Latallo, J. R. Baker, B. G. Orr, and M. M. Banaszak Holl. 2013. “Polyplex Exposure Inhibits Cell Cycle, Increases Inflammatory Response, and Can Cause Protein Expression Without Cell Division.” Molecular Pharmaceutics 10 (4): 1306–1317. doi:10.1021/mp300470d
   PubMed Web of Science ®Google Scholar
• Mecke, A., I. J. Majoros, A. K. Patri, J. R. Baker, M. M. Banaszak Holl, and B. G. Orr. 2005. “Lipid Bilayer Disruption by Polycationic Polymers: The Roles of Size and Chemical Functional Group.” Langmuir 21 (23): 10348–10354. doi:10.1021/la050629l.
   PubMed Web of Science ®Google Scholar
• Moreau, E., M. Domurado, P. Chapon, M. Vert, and D. Domurado. 2002. “Biocompatibility of Polycations: In Vitro Agglutination and Lysis of Red Blood Cells and In Vivo Toxicity.” Journal of Drug Targeting 10 (2): 161–173. doi:10.1080/10611860290016766.
   PubMed Web of Science ®Google Scholar
• Morris, C. J., G. Aljayyoussi, O. Mansour, P. Griffiths, and M. Gumbleton. 2017. “Endocytic Uptake, Transport and Macromolecular Interactions of Anionic PAMAM Dendrimers Within Lung Tissue.” Pharmaceutical Research 34 (12): 2517–2531. doi:10.1007/s11095-017-2190-7.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S. P., M. Davoren, and H. J. Byrne. 2010a. “In Vitro Mammalian Cytotoxicological Study of PAMAM Dendrimers – Towards Quantitative Structure Activity Relationships.” Toxicology In Vitro 24 (1): 169–177. doi:10.1016/j.tiv.2009.09.014.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S. P., F. M. Lyng, A. Garcia, M. Davoren, and H. J. Byrne. 2010b. “Mechanistic Studies of In Vitro Cytotoxicity of Poly(amidoamine) Dendrimers in Mammalian Cells.” Toxicology and Applied Pharmacology 248 (3): 259–268. doi:10.1016/j.taap.2010.08.016.
   PubMed Web of Science ®Google Scholar
• Mutin, M.,. F. Dignat‐George, and J. Sampol. 1997. “Immunologic Phenotype of Cultured Endothelial Cells: Quantitative Analysis of Cell Surface Molecules.” Tissue Antigens 50 (5): 449–458. doi:10.1111/j.1399-0039.1997.tb02899.x.
   PubMedGoogle Scholar
• Naha, P. C., M. Davoren, F. M. Lyng, and H. J. Byrne. 2010. “Reactive Oxygen Species (ROS) Induced Cytokine Production and Cytotoxicity of PAMAM Dendrimers in J774A.1 Cells.” Toxicology and Applied Pharmacology 246 (1–2): 91–99. doi:10.1016/j.taap.2010.04.014.
   PubMed Web of Science ®Google Scholar
• Naha, P., S. Mukherjee, and H. Byrne. 2018. “Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.” International Journal of Environmental Research and Public Health 15 (2): 338. doi:10.3390/ijerph15020338.
   PubMed Web of Science ®Google Scholar
• Najlah, M., S. Freeman, M. Khoder, D. Attwood, and A. D'emanuele. 2017. “In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.” Molecules 22. doi:10.3390/molecules22101661
   PubMed Web of Science ®Google Scholar
• Orecna, M., S. H. De Paoli, O. Janouskova, T. Z. Tegegn, M. Filipova, J. E. Bonevich, K. Holada, and J. Simak. 2014. “Toxicity of Carboxylated Carbon Nanotubes in Endothelial Cells Is Attenuated by Stimulation of the Autophagic Flux with the Release of Nanomaterial in Autophagic Vesicles.” Nanomedicine: Nanotechnology, Biology and Medicine 10 (5): e939–e948. doi:10.1016/j.nano.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Simak, J. 2016. “The effects of engineered nanomaterials on cultured endothelial cells.” In Handbook of immunological properties of engineered nanomaterials, edited by Marina A Dobrovolskaia and Scott E McNeil, 105–162. 2nd ed. World Scientific: Singapore. doi:10.1142/9789813140455_0005
   Google Scholar
• Šimák, J., K. Holada, and J. G. Vostal. 2002. “Release of Annexin V-binding Membrane Microparticles from Cultured Human Umbilical Vein Endothelial Cells after Treatment with Camptothecin.” BMC Cell Biology 3 (1): 11. doi:10.1186/1471-2121-3-11
   PubMedGoogle Scholar
• Steffel, J., T. F. Lüscher, and F. C. Tanner. 2006. “Tissue Factor in Cardiovascular Diseases.” Molecular Mechanisms and Clinical Implications 113: 722–731. doi:10.1161/CIRCULATIONAHA.105.567297.
   Google Scholar
• Tajarobi, F., M. El-Sayed, B. D. Rege, J. E. Polli, and H. Ghandehari. 2001. “Transport of Poly Amidoamine Dendrimers across Madin–Darby Canine Kidney Cells.” International Journal of Pharmaceutics 215 (1–2): 263–267. doi:10.1016/S0378-5173(00)00679-7.
   PubMed Web of Science ®Google Scholar
• Vidal, F., P. Vasquez, C. Diaz, D. Nova, J. Alderete, and L. Guzman. 2016. “Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons.” Molecular Pharmaceutics 13 (10): 3395–3403. doi:10.1021/acs.molpharmaceut.6b00381.
   PubMed Web of Science ®Google Scholar
• Wang, S., Y. Li, J. Fan, Z. Wang, X. Zeng, Y. Sun, P. Song, and D. Ju. 2014. “The Role of Autophagy in the Neurotoxicity of Cationic PAMAM Dendrimers.” Biomaterials 35 (26): 7588–7597. doi:10.1016/j.biomaterials.2014.05.029
   PubMed Web of Science ®Google Scholar
• Zwaal, R. F. A., P. Comfurius, and E. M. Bevers. 2005. “Surface Exposure of Phosphatidylserine in Pathological Cells.” Cellular and Molecular Life Sciences : CMLS 62 (9): 971–988. doi:10.1007/s00018-005-4527-3
   PubMed Web of Science ®Google Scholar